Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Efficacy and safety evaluation of claudin-4-targeted antitumor therapy using a human and mouse cross-reactive monoclonal antibody.

Hashimoto Y, Kawahigashi Y, Hata T, Li X, Watari A, Tada M, Ishii-Watabe A, Okada Y, Doi T, Fukasawa M, Kuniyasu H, Yagi K, Kondoh M.

Pharmacol Res Perspect. 2016 Sep 27;4(5):e00266. eCollection 2016 Oct.

2.

Comparative lipid analysis in the normal and cancerous organoids of MDCK cells.

Yoshizaki H, Ogiso H, Okazaki T, Kiyokawa E.

J Biochem. 2016 Jun;159(6):573-84. doi: 10.1093/jb/mvw001. Epub 2016 Jan 18.

PMID:
26783265
3.

Checkpoint Kinase 1 Activation Enhances Intestinal Epithelial Barrier Function via Regulation of Claudin-5 Expression.

Watari A, Hasegawa M, Yagi K, Kondoh M.

PLoS One. 2016 Jan 4;11(1):e0145631. doi: 10.1371/journal.pone.0145631. eCollection 2016.

4.

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.

Usami Y, Wu Y, Göttlinger HG.

Nature. 2015 Oct 8;526(7572):218-23. doi: 10.1038/nature15400. Epub 2015 Sep 30.

5.

Loss of anchorage primarily induces non-apoptotic cell death in a human mammary epithelial cell line under atypical focal adhesion kinase signaling.

Ishikawa F, Ushida K, Mori K, Shibanuma M.

Cell Death Dis. 2015 Jan 22;6:e1619. doi: 10.1038/cddis.2014.583.

6.

Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

Yu G, Herazo-Maya JD, Nukui T, Romkes M, Parwani A, Juan-Guardela BM, Robertson J, Gauldie J, Siegfried JM, Kaminski N, Kass DJ.

Am J Respir Crit Care Med. 2014 Oct 1;190(7):780-90. doi: 10.1164/rccm.201310-1903OC.

7.

Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity.

Ng KY, Yin T, Machida K, Wu YI, Mayer BJ.

Oncogene. 2015 May 14;34(20):2650-9. doi: 10.1038/onc.2014.210. Epub 2014 Jul 21.

8.

Characterisation of cytoplasmic DNA complementary to non-retroviral RNA viruses in human cells.

Shimizu A, Nakatani Y, Nakamura T, Jinno-Oue A, Ishikawa O, Boeke JD, Takeuchi Y, Hoshino H.

Sci Rep. 2014 May 30;4:5074. doi: 10.1038/srep05074.

9.

Stepwise assembly of fibrinogen is assisted by the endoplasmic reticulum lectin-chaperone system in HepG2 cells.

Tamura T, Arai S, Nagaya H, Mizuguchi J, Wada I.

PLoS One. 2013 Sep 10;8(9):e74580. doi: 10.1371/journal.pone.0074580. eCollection 2013.

10.

Insufficient ability of Rac1b to perturb cystogenesis.

Mori Y, Yagi S, Sakurai A, Matsuda M, Kiyokawa E.

Small GTPases. 2013 Jan-Mar;4(1):9-15. doi: 10.4161/sgtp.23311. Epub 2013 Jan 1.

11.

SNAP-23 regulates phagosome formation and maturation in macrophages.

Sakurai C, Hashimoto H, Nakanishi H, Arai S, Wada Y, Sun-Wada GH, Wada I, Hatsuzawa K.

Mol Biol Cell. 2012 Dec;23(24):4849-63. doi: 10.1091/mbc.E12-01-0069. Epub 2012 Oct 19.

12.

Activated Ras protein accelerates cell cycle progression to perturb Madin-Darby canine kidney cystogenesis.

Sakurai A, Matsuda M, Kiyokawa E.

J Biol Chem. 2012 Sep 14;287(38):31703-11. doi: 10.1074/jbc.M112.377804. Epub 2012 Jul 24.

13.

Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.

Cheung HW, Du J, Boehm JS, He F, Weir BA, Wang X, Butaney M, Sequist LV, Luo B, Engelman JA, Root DE, Meyerson M, Golub TR, Jänne PA, Hahn WC.

Cancer Discov. 2011 Dec;1(7):608-25. doi: 10.1158/2159-8290.CD-11-0046. Epub 2011 Oct 17.

14.

Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.

Tanaka A, Jinno-Oue A, Shimizu N, Hoque A, Mori T, Islam S, Nakatani Y, Shinagawa M, Hoshino H.

J Virol. 2012 Mar;86(6):2959-69. doi: 10.1128/JVI.05783-11. Epub 2012 Jan 11.

15.

From Hen House to Bedside: Tracing Hanafusa's Legacy from Avian Leukemia Viruses to SRC to ABL and Beyond.

Kharas MG, Daley GQ.

Genes Cancer. 2010 Dec;1(12):1164-9. doi: 10.1177/1947601911407327.

16.

Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation.

Zheng J, Machida K, Antoku S, Ng KY, Claffey KP, Mayer BJ.

Oncogene. 2010 Dec 2;29(48):6378-89. doi: 10.1038/onc.2010.369. Epub 2010 Aug 23.

17.

Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.

Birge RB, Kalodimos C, Inagaki F, Tanaka S.

Cell Commun Signal. 2009 May 10;7:13. doi: 10.1186/1478-811X-7-13.

18.

The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.

Arcaro A, Guerreiro AS.

Curr Genomics. 2007 Aug;8(5):271-306. doi: 10.2174/138920207782446160.

19.

A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation.

Schuman J, Chen Y, Podd A, Yu M, Liu HH, Wen R, Chen ZJ, Wang D.

Blood. 2009 May 7;113(19):4566-74. doi: 10.1182/blood-2008-08-176057. Epub 2009 Feb 5.

20.

Phospholipase Cgamma2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis.

Chen Y, Wang X, Di L, Fu G, Chen Y, Bai L, Liu J, Feng X, McDonald JM, Michalek S, He Y, Yu M, Fu YX, Wen R, Wu H, Wang D.

J Biol Chem. 2008 Oct 24;283(43):29593-601. doi: 10.1074/jbc.M802493200. Epub 2008 Aug 26.

Supplemental Content

Support Center